Wall Street punishes Lilly for latest drug setback; analysts grasp for answers
News that federal regulators rejected Lilly’s drug for arthritis sent the stock tumbling more than 5 percent Monday, and sent surprised analysts searching for answers.
Health Care
Articles
Lilly’s rheumatoid arthritis pill rejected by regulators
The drug, which has the proposed brand name Olumiant and is approved for use in Europe, was expected to be a big seller.
Fairbanks Foundation doles out $376,000 to train army of addiction specialists
The money, provided to the workforce initiative Ascend Indiana, will train up to 50 specialists a year targeting Indiana's growing opioid epidemic.
FDA issues warning to local doctor for breaking protocol on drug trial
The federal agency says the Indianapolis doctor studying Pfizer’s Chantix last year failed to keep accurate records and used patients who didn’t meet the trial requirements.
Blame game over drug prices escalates with new ad campaign
Broadening its efforts to defuse outrage over skyrocketing prices, the pharmaceutical industry’s lobbying association has started an advertising campaign urging insurers to share with customers more of the benefits of rebates they’ve negotiated.
Indiana needle exchange bill heads to governor, who backs it
The state Senate approved the measure Thursday by a 32-16 vote after lengthy discussion about needle exchanges, which aim to reduce the spread of infectious diseases by providing people with clean syringes and discouraging needle sharing
Marian medical school’s first graduates could fill primary-care dearth
Almost half of graduating students in Marian University’s novice College of Osteopathic Medicine are choosing to serve residencies in family medicine.
Insurance giant buying American Health Network doctor group
In the latest sign of health care consolidation, Indiana’s largest independent physician group has agreed to be acquired by the nation’s largest health insurer for $184 million.
Lilly among firms pulling ads from ‘O’Reilly Factor’
A sexual harassment scandal involving host Bill O’Reilly has prompted major advertisers such as Eli Lilly and Co. and several automakers to drop out. Indianapolis-based Angie’s List is among those sticking with the show.
White House woos GOP lawmakers with revised health care bill
Republicans entertained a fresh White House offer to revise the party's failed health care bill Tuesday as the GOP tried to resuscitate the measure that crashed less than two weeks ago.
FOCUS: Biosciences institute’s chief scientific officer aims to foster commercialization
Rainer Fischer’s goal is to spur collaboration in research and commercialization of life sciences products.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Senate’s $32.1B budget eschews cigarette tax hike
An Indiana Senate panel on Thursday advanced a two-year state budget plan with significant differences in funding for roads, entrepreneurship and education from the House’s plan.
UPDATE: Lilly to invest $85M in Indy as part of diabetes expansion
The expansion at the Lilly Technology Center southwest of downtown is part of an $850 million investment the company is making this year in its U.S. research labs, manufacturing plants and other operations.
Cancer often comes down to random chance, study says
Lifestyle and heredity get the most blame for cancer, but new research suggests random chance plays a bigger role than people realize.
House steers toward climactic vote on GOP health care bill
Republicans muscled their capstone health care overhaul past an initial barrier and toward a climactic roll call Friday, plunging ahead despite uncertainty over whether they had the votes to prevail.
Holcomb urges Congressional support of jeopardized GOP health care bill
The fate of the Republicans’ health care bill hangs in the balance, but Gov. Eric Holcomb is giving it his support.
Lilly CEO Ricks stands to make about $12M in first year at helm
Dave Ricks joined Lilly in 1996 and most recently served as president of Lilly Bio-Medicines. He took over as president and CEO on Jan. 1.
Advanced nurses in huge demand
In hospitals and clinics around Indiana, specialized nurses with advanced degrees and extensive training are booming in numbers.
Eli Lilly chasing psoriasis jackpot with Taltz
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.